Stay updated on IMCgp100 vs Investigator Choice in Uveal Melanoma Clinical Trial
Sign up to get notified when there's something new on the IMCgp100 vs Investigator Choice in Uveal Melanoma Clinical Trial page.

Latest updates to the IMCgp100 vs Investigator Choice in Uveal Melanoma Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check15 days agoChange DetectedThe page now lists 57 locations for the study, an increase from 56, and includes a new location in Bruxelles, Belgium. Additionally, several dates have been updated, including the addition of April 2025 dates.SummaryDifference1.0%
- Check22 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed descriptions of a Phase II study on IMCgp100 for advanced Uveal Melanoma, while adding a new revision number and the term 'Uveal Melanoma'.SummaryDifference28%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check58 days agoChange DetectedDifference0.1%
- Check72 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.9%
Stay in the know with updates to IMCgp100 vs Investigator Choice in Uveal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMCgp100 vs Investigator Choice in Uveal Melanoma Clinical Trial page.